​​​APHL’s Policy Program promotes the work of governmental public health laboratories by advocating for a sustainable laboratory network and voicing the impact of federal regulatory rules on public health laboratories.

Regulatory Response Activities

Zika Response

Select Agents

Common Rule

HHS Notice of Proposed Rulemaking to update the federal policies that protect human subjects in federally funded research

Laboratory Developed Tests

FDA Policy Guidance on Oversight of Laboratory Developed Tests

Semantic Interoperability of Laboratory Data

Promoting Semantic Interoperability of Laboratory Data Public Workshop

Pandemic Influenza Preparedness Framework

Antimicrobial Resistance Rapid, Point-of-Care Diagnostic Test Challenge

Request for Comment: Antimicrobial Resistance Rapid, Point-of-Care Diagnostic Test Challenge

Advocacy Letters ​​​

CMS Reimbursement Rates, October 2017

APHL joined 22 organizations in the laboratory community to raise concerns of the integrity of the data CMS collected when determining accurate weighted median of private payer rates for tests on the Clinical Laboratory Fee Schedule (CLFS). The letter urges CMS to involve all stakeholders when calculating and establishing pricing.

​FY18 CDC-NCEH Funding​, August 2017

APHL joined 24 public health organizations on a letter urging the leadership of the House and Senate Labor, HHS, Education and Related Agencies appropriations subcommittees to provide adequate fiscal year 2018 funding for the activities of the CDC National Center for Environmental Health.

Funding for Nondefense Discretionary Programs, March 2017

APHL joined over 2,000 organizations on a letter to Congress and the president urging them to work together to protect federal funding for nondefense programs, like those under the department of Health and Human Services. President Trump has proposed cutting that spending by $54 billion.

Repeal of Prevention and Public Health Fund

​APHL sent letters to Senate leadership stating to continue provide funding for critical public health programs that are currently funded from the Prevent​ion and Public Health Fund (PPHF), a component of the Affordable Care Act (ACA).

Newborn Screening Funding

​​APHL sent letters to leadership of Labor-HHS appropriations urging them to increase federal spending on newborn screening. to enable programmatic improvements that include assisting states in implementation of newly added disorders. 

Zika Funding

APHL joined on two letters to congressional leadership urging continued federal funding for Zika response activities. 

CDC Funding: Harmonizing Test Results, March 2017

APHL joined 16 laboratory organizations on a letter to the leadership of the Labor-HHS appropriations committee urging them to continue funding CDC's efforts on harmonizing laboratory test results.

CSTE-APHL: CDC Epidemiology and Laboratory Programs, March 2017

APHL has joined with CSTE to urge the leadership of the Congressional appropriations committees to provide appropriate funding for CDC surveillance and detection activities, with a focus on workforce efforts. 

Federal Hiring Freeze, February 2017

Vaccine Safety, February 2017

APHL joined over 350 public health and health organizations on a letter to the president expressing unequivocal support for the safety of vaccines. Robust vaccination programs are critical to improvements in the public's health.

Multiplex Nucleic Acid Amplification​ Test​, 2017

Toxic Substances Control Act​​​, 2016